GE HealthCare Technologies Inc.
GEHCNASDAQHealthcare● Active
$64.67
+$0.86(+1.35%)
Market Cap$29.4B
P/E Ratio—
52W High$89.77
52W Low$58.75
GE HealthCare Technologies Inc. (GEHC) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
GEHC · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 29, 2026EPS Actual
$0.99
Est. $1.04 · -4.8%
Revenue
$5.13B
Est. $5.04B · +1.8%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 29, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
GEHC reports quarterly as a NASDAQ-listed Medical - Healthcare Information Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $7.60B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$7.60B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 29, 2026 | $1.04 | — | — | — | $5.27B | — |
| ▼ Q2 FY2026 | Apr 29, 2026 | $1.04 | $0.99 | -4.8% | $5.13B | $5.04B | +1.8% |
| ▲ Q1 FY2026 | Feb 4, 2026 | $1.40 | $1.44 | +2.9% | $5.70B | $5.61B | +1.5% |
| ▲ Q4 FY2025 | Oct 29, 2025 | $1.05 | $1.07 | +1.9% | $5.14B | $5.09B | +1.1% |
| ▲ Q3 FY2025 | Jul 30, 2025 | $0.92 | $1.06 | +15.5% | $5.01B | $4.97B | +0.7% |
| ▲ Q2 FY2025 | Apr 30, 2025 | $0.91 | $1.01 | +10.5% | $4.78B | $4.66B | +2.5% |
| ▲ Q1 FY2025 | Feb 13, 2025 | $1.26 | $1.45 | +15.1% | $5.32B | $5.33B | -0.2% |
| ▲ Q4 FY2024 | Oct 30, 2024 | $1.05 | $1.14 | +8.6% | $4.86B | $4.87B | -0.1% |
Q3 FY2026
Jul 29, 2026
EPS Actual
—
EPS Est.
$1.04
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 29, 2026Miss
EPS Actual
$0.99
EPS Est.
$1.04
EPS Surpr.
-4.8%
Revenue
$5.13B
Q1 FY2026
Feb 4, 2026Beat
EPS Actual
$1.44
EPS Est.
$1.40
EPS Surpr.
+2.9%
Revenue
$5.70B
Q4 FY2025
Oct 29, 2025Beat
EPS Actual
$1.07
EPS Est.
$1.05
EPS Surpr.
+1.9%
Revenue
$5.14B
Q3 FY2025
Jul 30, 2025Beat
EPS Actual
$1.06
EPS Est.
$0.92
EPS Surpr.
+15.5%
Revenue
$5.01B
Q2 FY2025
Apr 30, 2025Beat
EPS Actual
$1.01
EPS Est.
$0.91
EPS Surpr.
+10.5%
Revenue
$4.78B
Q1 FY2025
Feb 13, 2025Beat
EPS Actual
$1.45
EPS Est.
$1.26
EPS Surpr.
+15.1%
Revenue
$5.32B
Q4 FY2024
Oct 30, 2024Beat
EPS Actual
$1.14
EPS Est.
$1.05
EPS Surpr.
+8.6%
Revenue
$4.86B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $1.86 | $1.89 | $1.91 | 4 |
| Q3 FY2028 | $1.49 | $1.51 | $1.53 | 6 |
| Q2 FY2028 | $1.40 | $1.42 | $1.44 | 4 |
| Q1 FY2028 | $1.29 | $1.31 | $1.33 | 4 |
| Q4 FY2027 | $1.67 | $1.70 | $1.73 | 3 |
| Q3 FY2027 | $1.35 | $1.37 | $1.39 | 4 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $6.4B | $6.5B | $6.6B | 3 |
| Q3 FY2028 | $5.7B | $5.8B | $5.8B | 5 |
| Q2 FY2028 | $5.6B | $5.7B | $5.7B | 3 |
| Q1 FY2028 | $5.5B | $5.6B | $5.7B | 3 |
| Q4 FY2027 | $6.2B | $6.3B | $6.3B | 4 |
| Q3 FY2027 | $5.6B | $5.6B | $5.7B | 5 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | Apr 29, 2026 | -4.8% | $68.50 | $59.49 | -13.15% |
| ▲ Q1 FY2026 | Feb 4, 2026 | +2.9% | $78.78 | $82.63 | +4.89% |
| ▲ Q4 FY2025 | Oct 29, 2025 | +1.9% | $79.40 | $77.38 | -2.54% |
| ▲ Q3 FY2025 | Jul 30, 2025 | +15.5% | $77.72 | $71.64 | -7.82% |
| ▲ Q2 FY2025 | Apr 30, 2025 | +10.5% | $68.09 | $70.33 | +3.29% |
| ▲ Q1 FY2025 | Feb 13, 2025 | +15.1% | $85.90 | $93.48 | +8.82% |
| ▲ Q4 FY2024 | Oct 30, 2024 | +8.6% | $85.27 | $87.20 | +2.26% |
| ▲ Q3 FY2024 | Jul 31, 2024 | +2.0% | $82.65 | $84.63 | +2.40% |
Q2 FY2026-13.15%
Report Date
Apr 29, 2026
EPS Beat/Miss
-4.8%
Price Before
$68.50
Price After
$59.49
Q1 FY2026+4.89%
Report Date
Feb 4, 2026
EPS Beat/Miss
+2.9%
Price Before
$78.78
Price After
$82.63
Q4 FY2025-2.54%
Report Date
Oct 29, 2025
EPS Beat/Miss
+1.9%
Price Before
$79.40
Price After
$77.38
Q3 FY2025-7.82%
Report Date
Jul 30, 2025
EPS Beat/Miss
+15.5%
Price Before
$77.72
Price After
$71.64
Q2 FY2025+3.29%
Report Date
Apr 30, 2025
EPS Beat/Miss
+10.5%
Price Before
$68.09
Price After
$70.33
Q1 FY2025+8.82%
Report Date
Feb 13, 2025
EPS Beat/Miss
+15.1%
Price Before
$85.90
Price After
$93.48
Q4 FY2024+2.26%
Report Date
Oct 30, 2024
EPS Beat/Miss
+8.6%
Price Before
$85.27
Price After
$87.20
Q3 FY2024+2.40%
Report Date
Jul 31, 2024
EPS Beat/Miss
+2.0%
Price Before
$82.65
Price After
$84.63
Avg Beat Reaction+1.61%
Avg Miss Reaction-13.15%
Beat Rate7 / 8 quarters
Largest Move-13.15% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: GEHC ends December
GE HealthCare Technologies Inc. (GEHC) most recently reported earnings on April 29, 2026 for Q2 FY2026, posting EPS of $0.99 — missing the analyst consensus of $1.04 by -4.8%. The next GEHC earnings date is expected around September 1, 2026.
Each quarter, investors track GEHC earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. GEHC revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
GEHC's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
GEHC earnings · 5 questionsGE HealthCare Technologies Inc.'s next earnings report is expected around September 1, 2026. GEHC typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; GEHC historically reports after market close (AMC).
GEHC earnings datewhen is GEHC earningsGEHC next earnings datewhen does GEHC report earningsGEHC earnings calendar
▸ Source: FMP · GE HealthCare Technologies Inc. SEC filings · US GAAP · GE HealthCare Technologies Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026